Clinical Trials

NCT05534438 | RECRUITING | PHASE2
46 participants

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-09-06
Completion:
2026-09-06
Conditions
  • Oligometastatic Breast Carcinoma
  • Breast Cancer
  • Metastatic Breast Cancer
  • Metastatic Breast Carcinoma
  • ER+ Breast Cancer
  • HER2+ Breast Cancer
Interventions
  • RADIATION
No Results Yet
NCT05503264 | ACTIVE_NOT_RECRUITING | PHASE3
122 participants

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-09-27
Completion:
2026-12-16
Conditions
  • NMDAR Autoimmune Encephalitis
  • LGI1 Autoimmune Encephalitis
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05458674 | ACTIVE_NOT_RECRUITING | PHASE2
17 participants

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2024-01-30
Completion:
2027-06-01
Conditions
  • Breast Cancer
  • Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT05451108 | COMPLETED | NA
7 participants

Pectus Excavatum Camouflage

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2021-12-14
Completion:
2025-12-18
Conditions
  • Pectus Excavatum
Interventions
  • DEVICE
No Results Yet
NCT05437757 | COMPLETED | NA
19 participants

Scaffold-guided Breast Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-06-15
Completion:
2025-12-10
Conditions
  • Breast Implant Revision
  • Congenital Breast Defect Correction
Interventions
  • DEVICE
No Results Yet
NCT05411094 | ACTIVE_NOT_RECRUITING | PHASE1
18 participants

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2023-05-22
Completion:
2026-08-10
Conditions
  • Locally Advanced Pancreatic Carcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT05392881 | RECRUITING
1000 participants

Interstitial Lung Disease Research Unit Biobank

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-10
Start Date:
2021-08-09
Completion:
2031-08-01
Conditions
  • Interstitial Lung Disease
  • Sarcoidosis
  • Idiopathic Pulmonary Fibrosis
  • Pulmonary Fibrosis
  • Hypersensitivity Pneumonitis
No Results Yet
NCT05388929 | ACTIVE_NOT_RECRUITING | PHASE4
164 participants

Methocarbamol in Ventral and Inguinal HR

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-06-23
Completion:
2027-06-30
Conditions
  • Ventral Hernia
  • Inguinal Hernia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page